1.
Plasma sICAM-1 correlates with tumor volume before primary radiochemotherapy of HNSCC patients. Radiol Oncol. 2022;56(4):501-507. Accessed September 23, 2026. https://www.radioloncol.com/index.php/ro/article/view/3961